Your privacy is very important to us.When you visit our website,please agree to the use of all cookies.For more information about personal data processing,please go t0 《Privacy Policy Statement》

中
En
About Us
Overview
Founder
Platform
Milestones
Culture
Honors
Core Technology
Technological platforms
Pipeline
Academic achievements
Clinical Trials
News
Company News
Media News
Join Us
Social Recruitment
Campus Recruitment
Contact
linchuangshiyan.jpg d1_banph.jpg

Clinical Trials
A Multicenter, Randomized, Controlled,Open Label, Phase II Trial of Autologous Tumor Infiltrating Lymphocytes (GC101 TIL) in Subjects With Advanced Melanoma（MIZAR-003）

Beijing Cancer Hospital, Fujian Cancer Hospital, Fudan University Shanghai Cancer Center, Zhejiang Cancer hospital, Hunan Cancer Hospital, Henan Cancer Hospital, Cancer Hospital of Shandong First Medical University, etc..

Learen More +